Editorial

DOI: 10.4244/EIJ-E-26-00001

Privileged witnesses: how interventional cardiologists can validate experimental evidence in practice

Javier Escaned1, MD, PhD; Guus de Waard2, MD, PhD

Immersed in our everyday activities and busy work schedules, we run the risk of failing to appreciate our privileged position as interventional cardiologists to witness and gain insights into many aspects of cardiac physiology. Fortunately, every now and then, we come across fresh observations that support or reinforce a body of knowledge largely obtained in the experimental laboratory. This is indeed the case for the research published on coronary flow regulation in this issue of EuroIntervention by Marin and colleagues1.

To trace the context of this research, we should go back to the French physiologist Claude Bernard, who, in 1865, coined the term “milieu intérieur” and the associated concept of homeostasis to describe the steady internal physical and chemical conditions that are autonomously maintained in living organisms. One specific case of homeostasis is regulating arterial blood supply under shifting conditions. In 1902, Bayliss found that hindlimb arterioles regulate flow through an intrinsic myogenic reflex that reacts to variations of intraluminal pressure, thus keeping flow constant before arterial pressure shifts2, and in 1959, Lassen demonstrated the existence of a cerebral...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 22 Number 5
Mar 2, 2026
Volume 22 Number 5
View full issue


Key metrics

Suggested by Cory

EXPERT REVIEW

10.4244/EIJ-D-17-00503 Aug 25, 2017
State of the art: pressure wire and coronary functional assessment
Echavarria-Pinto M et al
free

Editorial

10.4244/EIJ-D-26-00289 May 4, 2026
Expanding physiology beyond the wire: will 2026 be the defining year?
Campo G and Biscaglia S
free

10.4244/EIJV17I4A47 Jul 20, 2021
Coronary flow capacity: where to next?
Johnson NP and Gould K
free

10.4244/AIJV14I2A19 Jun 20, 2018
Time for caution interpreting coronary physiology in aortic stenosis?
Davies J and Piek J
free

Editorial

10.4244/EIJ-E-24-00022 Jun 3, 2024
Epicardial inflow versus myocardial distribution: average regional transmural coronary flow is not enough
Johnson NP and Gould K
free

10.4244/EIJV13I2A20 Jun 2, 2017
Coronary physiological parameters at a crossroads
Davies J et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved